Hypertension (high blood pressure) decisions — 2025

The Board denied the Veteran's claims for increased ratings and service connection, as the evidence did not support a compensable rating for sinusitis or hypertension, and there was no current diagnosis of cyclic vomiting syndrome related to service.

The Board granted the reinstatement of a 20 percent rating for right and left lower extremity peripheral neuropathy of the femoral nerve, as well as a 10 percent rating for hypertension, effective February 9, 2024.

The Board granted service connection for diabetes mellitus II and hypertension, both linked to herbicide exposure during active service. The claim for syncope was remanded.

The Board denied the Veteran's claim for service connection for hypertension, as there was no evidence of onset during service or within one year of separation from service, and no other evidence linking the condition to his military service.

The Board denied the claims for service connection for hypertension, diabetes mellitus, type 2, arthritis of the right hand, residuals of metacarpal fracture of the 4th digit of the right hand, and nerve damage of the right wrist as secondary to a service-connected disability. The claim for a compensable evaluation for the service-connected fracture of the 5th digit of the right hand was also denied.

The Board denied service connection for hypertension, a lumbar spine disability, aneurysm and residuals secondary to hypertension, and remanded the claim for a psychiatric disorder.

The Board remands the claims for service connection for type II diabetes mellitus and hypertension to ensure that there is a complete record upon which to decide the Veteran's claims, including verifying his in-service exposure to herbicide agents.

The Veteran's liver disability is granted, while diabetes mellitus, hypertension, and sleep apnea are denied.

The Veteran's claim for service connection for hypertension on a direct basis prior to August 10, 2022 was granted. Other claims were remanded.

The Board remands the claims for service connection for carpal tunnel syndrome, hypertension, thrombocytopenia, and obstructive sleep apnea to obtain additional medical opinions.

The Board denied an effective date earlier than August 10, 2022, for the grant of service connection for hypertension and HHD under the PACT Act.

The Board denied the veteran's claim for service connection for hypertension due to a lack of evidence showing a current disability.

The Board granted an earlier effective date of March 16, 2021, for the award of service connection for hypertension due to herbicide exposure and denied service connection for a heart disability. The rating for PTSD with depressive disorder was also denied.

The appeal was dismissed due to an improper concurrent election of review options.

The Board denied the Veteran's claim for a compensable rating for hypertension as there was no evidence of diastolic pressure predominantly 100 or more, or systolic pressure predominantly 160 or more during the appeal period.

The Board granted service connection for migraine headaches and denied service connection for hypertension.

The Board granted an initial 10 percent evaluation for hypertension based on historical blood pressure readings showing diastolic pressure predominantly measured as 100 or more and requiring continuous medication for control.

The Board denied the Veteran's claim for an initial compensable rating for hypertension as the evidence did not show diastolic pressure predominantly 100 or more, or systolic pressure predominantly 160 or more.

The Board denied service connection for various conditions, including an acquired psychiatric disorder, tinnitus, hypertension, a dental and oral disorder, gastroesophageal reflux disease, headaches, a lumbar spine disorder, a cervical spine disorder, right ankle disorder, left ankle disorder, right wrist disorder, and left wrist disorder.

The Board granted service connection for a low back disability, to include degenerative disc disease. The claims for hypertension and diabetes mellitus type II were remanded.